10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2022 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2022 10-K (Filed: Feb 8, 2023) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2022 | Dec 31, 2021 | |
| Assets: | ||
| Cash and cash equivalents | $ 12,945 | 9,408 |
| Investments | 2,778 | 3,117 |
| Accounts receivable, net | 27,276 | 24,431 |
| Inventories | 19,090 | 17,760 |
| Assets held for sale | 908 | 0 |
| Other current assets | 2,685 | 5,292 |
| Total current assets | 65,682 | 60,008 |
| Long-term investments | 21,096 | 23,025 |
| Property and equipment, net | 12,873 | 12,896 |
| Operating lease right-of-use assets | 17,872 | 19,122 |
| Goodwill | 78,150 | 79,121 |
| Intangible assets, net | 24,754 | 29,026 |
| Separate accounts assets | 3,228 | 5,087 |
| Other assets | 4,620 | 4,714 |
| Total assets | 228,275 | 232,999 |
| Liabilities: | ||
| Accounts payable | 14,838 | 12,544 |
| Pharmacy claims and discounts payable | 19,423 | 17,330 |
| Health care costs payable | 10,406 | 8,808 |
| Policyholders funds | 1,500 | 4,301 |
| Accrued expenses | 18,745 | 17,670 |
| Other insurance liabilities | 1,140 | 1,303 |
| Current portion of operating lease liabilities | 1,678 | 1,646 |
| Current portion of long-term debt | 1,778 | 4,205 |
| Liabilities held for sale | 228 | 0 |
| Total current liabilities | 69,736 | 67,807 |
| Long-term operating lease liabilities | 16,800 | 18,177 |
| Long-term debt (1) | 50,476 | 51,971 |
| Deferred income taxes | 3,880 | 6,270 |
| Separate accounts liabilities | 3,228 | 5,087 |
| Other long-term insurance liabilities | 6,108 | 6,402 |
| Other long-term liabilities | 6,732 | 1,904 |
| Total liabilities | 156,960 | 157,618 |
| Commitments and contingencies (Note 16) | ||
| Shareholders equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | 0 | 0 |
| Common stock, par value $0.01: 3,200 shares authorized; 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital surplus | 48,193 | 47,377 |
| Treasury stock, at cost: 458 and 422 shares at December 31, 2022 and 2021 | (31,858) | (28,173) |
| Retained earnings | 56,145 | 54,906 |
| Accumulated other comprehensive income (loss) | (1,465) | 965 |
| Total CVS Health shareholders equity | 71,015 | 75,075 |
| Noncontrolling interests | 300 | 306 |
| Total shareholders equity | 71,315 | 75,381 |
| Total liabilities and shareholders equity | 228,275 | 232,999 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |